Evidence map›Paper›PMID 23000204›Full record

ReviewFrontiers in neuroendocrinology2012

Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise.

Jennifer C Felger, Andrew H Miller

Open access · greenAbstract readReview
In one paragraph

Review in Frontiers in neuroendocrinology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 222 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
222citing papers in PubMed, 5 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

222 citing papers in PubMed, 5 syntheses or guidelines pooled it, 373 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Randomized Controlled Phase II Evaluation of Two Dose Levels of Bupropion Versus Placebo for Sexual Desire in Female Cancer Survivors: NRG-CC004.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022
    Trial
  8. Biological motion during inflammation in humans.Brain, behavior, and immunity · 2020
    Trial
  9. Trial
  10. Trial
  11. Lipopolysaccharide Alters Motivated Behavior in a Monetary Reward Task: a Randomized Trial.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2017
    Trial
  12. Trial
  13. Trial
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

162 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jennifer C FelgerDepartment of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA.
Andrew H Miller
Emory University · US

Funding

Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Hannah LF Cooper · 2002 to 2026
$74.0M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025008 · NCRR · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2007 to 2011
$29.0M
Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
X LINKED NYSTAGMUS SYNDROME WITH FEATURES OF ALBINISMM01RR000039 · NCRR · EMORY UNIVERSITY · PI BRANN, ALFRED W · 1985 to 2007
$21.3M
Projevt 5: Effects of the CRF1 receptor antagonist in patients w/PTSD: a plcebocoU19MH069056 · NIMH · EMORY UNIVERSITY · PI ROTHBAUM, BARBARA O · 2003 to 2013
$15.4M
Phenotyping Major Depression with Increased InflammationR01MH087604 · NIMH · EMORY UNIVERSITY · PI MILLER, ANDREW H · 2010 to 2014
$2.2M
Dopaminergic Mechanisms of Cytokine-Induced Behavioral ChangeR01MH083746 · NIMH · EMORY UNIVERSITY · PI MILLER, ANDREW H · 2009 to 2012
$1.5M
HIV/AIDS CLINICAL RESEARCH TRAINING PROGRAMT32MH020018 · NIMH · EMORY UNIVERSITY · PI MILLER, ANDREW H · 1998 to 2008
$1.3M
Pathophysiology of IFN-alpha-induced Sleep DisturbancesR01HL073921 · NHLBI · EMORY UNIVERSITY · PI MILLER, ANDREW H · 2004 to 2008
$1.3M
Fronto-Striatal Dysfunction in IFNa-Induced DepressionR01MH067990 · NIMH · EMORY UNIVERSITY · PI MILLER, ANDREW H · 2004 to 2008
$1.3M
Neuroimmune Mechanisms of Glucocorticoid ResistanceR01MH075102 · NIMH · EMORY UNIVERSITY · PI MILLER, ANDREW H · 2006 to 2010
$1.0M
Pathology and Treatment of Cytokine-Induced DepressionK05MH069124 · NIMH · EMORY UNIVERSITY · PI MILLER, ANDREW H · 2004 to 2008
$585k
NCATS NIH HHS UL1 TR000454NCRR NIH HHS M01 RR000039NCRR NIH HHS M01RR0039NCRR NIH HHS UL1 RR025008NCRR NIH HHS UL1RR025008NHLBI NIH HHS R01 HL073921NHLBI NIH HHS R01HL073921NIAID NIH HHS P30 AI050409NIAID NIH HHS P30AI050409NIMH NIH HHS F32 MH093054NIMH NIH HHS F32MH093054NIMH NIH HHS K05 MH069124NIMH NIH HHS K05MH069124NIMH NIH HHS R01 MH067990NIMH NIH HHS R01 MH075102NIMH NIH HHS R01MH075102NIMH NIH HHS R01 MH083746NIMH NIH HHS R01 MH087604NIMH NIH HHS T32 MH020018NIMH NIH HHS T32MH020018NIMH NIH HHS U19 MH069056NIMH NIH HHS U19MH069056
6 · The paper itself

Abstract

Data suggest that cytokines released during the inflammatory response target subcortical structures including the basal ganglia as well as dopamine function to acutely induce behavioral changes that support fighting infection and wound healing. However, chronic inflammation and exposure to inflammatory cytokines appears to lead to persisting alterations in the basal ganglia and dopamine function reflected by anhedonia, fatigue, and psychomotor slowing. Moreover, reduced neural responses to hedonic reward, decreased dopamine metabolites in the cerebrospinal fluid and increased presynaptic dopamine uptake and decreased turnover have been described. This multiplicity of changes in the basal ganglia and dopamine function suggest fundamental effects of inflammatory cytokines on dopamine synthesis, packaging, release and/or reuptake, which may sabotage and circumvent the efficacy of current treatment approaches. Thus, examination of the mechanisms by which cytokines alter the basal ganglia and dopamine function will yield novel insights into the treatment of cytokine-induced behavioral changes and inflammatory malaise.

Indexed as

AnimalsBasal GangliaBehavior, AnimalCytokinesDopamineFatigueGlutamic AcidHumansIllness BehaviorInflammationInterferon-alphaMacaca mulattaRewardSelective Serotonin Reuptake InhibitorsSynaptic TransmissionCytokinesDopamineGlutamic AcidInterferon-alphaSelective Serotonin Reuptake Inhibitors

Identifiers

PMID23000204
PMCPMC3484236
OpenAlexW2069604660

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.